As the disease develops, capillaries become progressively non-perfused resulting in retinal ischemia and hypoxia which in turn drives upregulation of pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and activation of inflammatory pathways. The gene discussed is VEGFA; the disease is retinal ischemia.